122 related articles for article (PubMed ID: 8877348)
21. [Maintenance therapy in reflux esophagitis].
Katsoulis S; Fölsch UR
Z Gastroenterol; 1997 Feb; 35(2):159-61. PubMed ID: 9163230
[No Abstract] [Full Text] [Related]
22. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group.
Andersson T; Hassall E; Lundborg P; Shepherd R; Radke M; Marcon M; Dalväg A; Martin S; Behrens R; Koletzko S; Becker M; Drouin E; Göthberg G
Am J Gastroenterol; 2000 Nov; 95(11):3101-6. PubMed ID: 11095324
[TBL] [Abstract][Full Text] [Related]
24. [Cimetidine versus ranitidine in the treatment of peptic esophagitis].
Noya G; Dettori G; Muscas A; Spirito R; Niolu P; Marongiu G; Biglioli P
Minerva Med; 1983 Apr; 74(14-15):787-90. PubMed ID: 6132354
[TBL] [Abstract][Full Text] [Related]
25. How do you spell relief in reflux esophagitis? PPI!
Fennerty MB
Gastroenterology; 1996 Sep; 111(3):826-7. PubMed ID: 8780593
[No Abstract] [Full Text] [Related]
26. Treatment of reflux oesophagitis resistant to H2-receptor antagonists.
Klinkenberg-Knol EC; Meuwissen SG
Digestion; 1989; 44 Suppl 1():47-53. PubMed ID: 2575061
[TBL] [Abstract][Full Text] [Related]
27. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
McKenna CJ; Mills JG; Goodwin C; Wood JR
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
[TBL] [Abstract][Full Text] [Related]
28. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
[TBL] [Abstract][Full Text] [Related]
29. [Lansoprazol].
Ponce J; Nos P
Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
[No Abstract] [Full Text] [Related]
30. Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole.
Orel R; Brecelj J; Homan M; Heuschkel R
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):376-83. PubMed ID: 16641575
[TBL] [Abstract][Full Text] [Related]
31. [Omeprazole in the therapy of acid-induced diseases].
Simon B; Dammann HG; Müller P
Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
[TBL] [Abstract][Full Text] [Related]
32. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists.
Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Snel P; Meuwissen SG
Scand J Gastroenterol Suppl; 1989; 166():88-93; discussion 94. PubMed ID: 2574911
[TBL] [Abstract][Full Text] [Related]
33. [Therapy of reflux esophagitis].
Berges W; Wienbeck M
Z Gastroenterol; 1993 Nov; 31 Suppl 5():15-7. PubMed ID: 7910994
[No Abstract] [Full Text] [Related]
34. Long-term therapy for reflux esophagitis.
Tytgat GN
N Engl J Med; 1995 Oct; 333(17):1148-50. PubMed ID: 7565956
[No Abstract] [Full Text] [Related]
35. [Reflux esophagitis. Step-down instead of step-up].
MMW Fortschr Med; 2006 Nov; 148(47):56-7. PubMed ID: 17168191
[No Abstract] [Full Text] [Related]
36. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.
Holloway RH; Dent J; Narielvala F; Mackinnon AM
Gut; 1996 May; 38(5):649-54. PubMed ID: 8707107
[TBL] [Abstract][Full Text] [Related]
37. Reflux esophagitis.
Tytgat GN; Nio CY; Schotborgh RH
Scand J Gastroenterol Suppl; 1990; 175():1-12. PubMed ID: 1978403
[TBL] [Abstract][Full Text] [Related]
38. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.
Klinkenberg-Knol EC; Meuwissen SG
Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868
[TBL] [Abstract][Full Text] [Related]
39. Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output.
Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Meuwissen SG
Scand J Gastroenterol; 1990 Nov; 25(11):1144-50. PubMed ID: 1980377
[TBL] [Abstract][Full Text] [Related]
40. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.
Koop H; Arnold R
Dig Dis Sci; 1991 May; 36(5):552-7. PubMed ID: 1673654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
